Manufacturer
123 recalls in our database name Pfizer Inc. as the manufacturing or recalling firm.
Of the 123 recalls from Pfizer Inc. we have scored against our rubric, 6 (5%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 28 (23%) are Severe.
Which agencies issued them
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Pfizer is recalling 16,000 TORISEL kits because impurities in the diluent may cause crystals to form after cold storage. The TORISEL drug vials are not affected.
Pfizer is recalling 93,800 vials of Depo-Medrol (methylprednisolone acetate) because a stability test showed a pH level below the registered specification.
Pfizer is recalling 22,461 bottles of Cardura XL 4 mg tablets because the product may not meet specifications for a product degradant.
Pfizer is recalling Viracept (nelfinavir mesylate) tablets because some bottles were labeled with an incorrect expiration date of 11/2016 instead of 09/2016.
Pfizer is recalling 4,155 bottles of Greenstone brand fluconazole oral suspension because some bottles have defective tamper-evident rings.
Pfizer is recalling Tikosyn (dofetilide) 500 mcg capsules because a single 250 mcg capsule was found in one bottle. The recall covers 23,064 bottles distributed nationwide.
Pfizer is recalling specific bottles of Glucotrol XL tablets because they failed to meet dissolution specifications at the 8-hour stability timepoint.
Pfizer is recalling specific lots of Zithromax (azithromycin) injection due to out-of-specification results for a degradant.
Pfizer is recalling specific lots of Prempro tablets because they may not meet dissolution specifications for conjugated estrogens.
Pfizer is recalling specific lots of Prempro tablets because they may not meet dissolution specifications for conjugated estrogens.
Pfizer is recalling specific lots of Norpace CR (disopyramide phosphate) capsules because they failed to meet dissolution specifications.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl (levothyroxine sodium) tablets because they emit a strong chemical odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after opening. Consumers should stop using the affected products.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong chemical odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after opening. The recall covers 10,121 bottles distributed nationwide and in Puerto Rico.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling 10,920 TORISEL (temsirolimus) kits nationwide due to a lack of assurance of sterility and potential low-level endotoxins in the diluent vials.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Pfizer
American multinational pharmaceutical and biotechnology corporation
Source: Wikidata (Q206921), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.